Castle Biosciences, Inc. - Common stock — Liquidità (NASDAQ:CSTL) | MetaTrader

Apri il grafico completo Full chart

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Flusso di cassa derivante dalle attività operative 9.87 M-18.98 M-41.66 M-5.63 M64.87 M64.35 M 48.25 M Flussi di cassa derivanti dalle attività di investimento -4.75 M-66.66 M-166.54 M-16.18 M-50.14 M-60.37 M -63.74 M Liquidità derivante dalle attività di finanziamento 305.89 M5.42 M1.51 M-2.3 M6.14 M-6.96 M -10.44 M Liquidità libera 9.87 M-18.98 M-41.66 M-5.63 M64.87 M28.33 M 4.52 M

Notizie

BTIG abbassa il target su Castle Biosciences per i costi più elevati

Castle Biosciences Q1 2026: ricavi sopra le attese, guidance alzata

Castle Biosciences, Inc. (CSTL) Reports Q1 Loss, Beats Revenue Estimates

Alkermes' Q1 Earnings & Revenues Beat Estimates, Stock Rises

OCGN Falls on Wider Q1 Loss Despite Strong Pipeline Progress Outlook

EDIT's Q1 Loss Narrower Than Expected, Pipeline in Focus

Repligen's Q1 Earnings & Revenues Beat Estimates, Stock Rises

JAZZ Stock Jumps as Q1 Earnings & Sales Surpass Expectations

BioMarin Q1 Earnings Miss, Sales Beat, '26 Revenue Guidance Raised

Krystal Biotech Q1 Earnings & Sales Beat Estimates, Pipeline in Focus

AXSM Q1 Loss Widens, Revenues Jump on Higher Auvelity Sales

Wall Street Analysts Predict an 85.15% Upside in Castle Biosciences (CSTL): Here's What You Should Know